• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Risk factors and outcome of Stroke in renal transplant recipients
This article is protected by copyright. All rights reserved.
Source: Clinical Transplantation - May 23, 2016 Category: Transplant Surgery Authors: Mark D. Findlay, Peter C. Thomson, Rachael MacIsaac, Alan G. Jardine, Rajan K. Patel, Kathryn K. Stevens, Elaine Rutherford, Marc Clancy, Colin C. Geddes, Jesse Dawson, Patrick B. Mark Tags: Original Article Source Type: research

Cerebrovascular Events in 20 ‐years of Follow‐Up after Liver Transplantation. An Underestimated Issue?
ConclusionLT recipients seem to have a considerably increased risk of CBVE. Long‐term surveillance should take this into account and screening may be extended accordingly. The progressive impairment of renal function in the long‐term LT survivors may be one reason for the underestimation of CBVE in this patient group.This article is protected by copyright. All rights reserved.
Source: Clinical Transplantation - July 21, 2016 Category: Transplant Surgery Authors: Wenzel Schoening, Niklas Buescher, Nadja Neidel, Michael Helbig, Andreas Andreou, Andreas Pascher, Marcus Bahra, Johann Pratschke, Daniel Seehofer Tags: Original Article Source Type: research

Cerebrovascular events in 20 years of follow ‐up after liver transplantation: an underestimated issue?
ConclusionLT recipients seem to have a considerably increased risk of CBVE. Long‐term surveillance should take this into account, and screening may be extended accordingly. The progressive impairment of renal function in the long‐term LT survivors may be one reason for the underestimation of CBVE in this patient group.
Source: Clinical Transplantation - August 16, 2016 Category: Transplant Surgery Authors: Wenzel Schoening, Niklas Buescher, Nadja Neidel, Michael Helbig, Andreas Andreou, Andreas Pascher, Marcus Bahra, Johann Pratschke, Daniel Seehofer Tags: Original Article Source Type: research

Patent Foramen Ovale Repair at the Time of Double Lung Transplantation: Necessary or Not?
ConclusionsThe protective effect of PFO repair remains unclear. However, is not associated with an increased incidence of stroke or postoperative mortality following LTx. This suggests that repair of PFO, with its inherent increase in surgical complexity, is not required and outcomes are acceptable.This article is protected by copyright. All rights reserved.
Source: Clinical Transplantation - January 1, 2018 Category: Transplant Surgery Authors: Nicholas R. Hess, Stephen A. Esper, Marie Tuft, Matthew Morrell, Jonathan D'Cunha Tags: Original Article Source Type: research

Extracorporeal Membrane Oxygenation: Experience In Acute Graft Failure After Heart Transplantation
ConclusionTemporary ECMO support for postoperative output failure is an acceptable option as a last resort for otherwise doomed patients with fatal graft failure after HTx. The small fraction of patients surviving, appear to have a decent long‐term prognosis.This article is protected by copyright. All rights reserved.
Source: Clinical Transplantation - April 1, 2014 Category: Transplant Surgery Authors: Sven Lehmann, Madlen Uhlemann, Christian D. Etz, Jens Garbade, Thomas Schroeder, Michael Borger, Martin Misfeld, Hartmuth B Bittner, Friedrich Wilhelm Mohr Tags: Original Article Source Type: research

The Policy of Placing Older Donors into Older Recipients: Is it Worth the Risk?
ConclusionsUse of older donors (50yrs) in older recipients (60yrs) results in lower 5‐yr survival and freedom from CAV. Caution is required in these cases. Larger studies are warranted to confirm findings.This article is protected by copyright. All rights reserved.
Source: Clinical Transplantation - May 6, 2014 Category: Transplant Surgery Authors: Yonah Solaiman Tehrani, Zhe Yu, Minh Luu, Frank Liou, Matthew Rafiei, Michele Hamilton, Jon Kobashigawa Tags: Original Article Source Type: research

Incidence, risk factors and outcomes of stroke post‐transplantation in patients receiving a steroid sparing immunosuppression protocol
This article is protected by copyright. All rights reserved.
Source: Clinical Transplantation - September 1, 2014 Category: Transplant Surgery Authors: Michelle Willicombe, Nicola Kumar, Dawn Goodall, Candice Clarke, Adam G McLean, Albert Power, David Taube Tags: Original Article Source Type: research

Incidence, risk factors, and outcomes of stroke post‐transplantation in patients receiving a steroid sparing immunosuppression protocol
This study has identified subgroups of patients who are at increased risk of CVA post‐transplant in patients otherwise receiving a steroid sparing immunosuppression protocol.
Source: Clinical Transplantation - November 19, 2014 Category: Transplant Surgery Authors: Michelle Willicombe, Nicola Kumar, Dawn Goodall, Candice Clarke, Adam G. McLean, Albert Power, David Taube Tags: Original Article Source Type: research

Effect of Moderately Intense Perioperative Glucose Control on Renal Allograft Function: A Pilot Randomized Controlled Trial in Renal Transplantation
This article is protected by copyright. All rights reserved.
Source: Clinical Transplantation - July 15, 2016 Category: Transplant Surgery Authors: Justin Parekh, Garrett R Roll, Steven Wisel, Robert J. Rushakoff, Ryutaro Hirose Tags: Original Article Source Type: research

Prolonged Corrected QT Interval in the Donor Heart: Is There a Risk?
ConclusionQTc > 500 msec in the donor heart appears to be an independent risk factor for the development of early CAV after heart transplantation possibly due to a higher immunological risk.This article is protected by copyright. All rights reserved.
Source: Clinical Transplantation - May 1, 2017 Category: Transplant Surgery Authors: Derek Leong, Tamar Aintablian, Michelle Kittleson, Michael Olymbios, Jignesh Patel, David H. Chang, Jon Kobashigawa Tags: Original Article Source Type: research

Effect of Diltiazem on Exercise Capacity after Heart Transplantation
ConclusionsThis study showed that Diltiazem treatment reduces ST, may improve cardiac allograft function and exercise tolerance during the first year after HTx.This article is protected by copyright. All rights reserved.
Source: Clinical Transplantation - May 1, 2017 Category: Transplant Surgery Authors: Sara Varnado, Yael Peled ‐Potashnik, Ashley Huntsberry, Brian D Lowes, Ronald Zolty, Adam Burdorf, Elizabeth R Lyden, Michael J Moulton, John Y Um, Eugenia Raichlin Tags: Original Article Source Type: research

Multivisceral Transplant is a Viable Treatment Option for Patients with Nonresectable Intraabdominal Fibromatosis
ConclusionsMVT is a viable option for patients who have nonresectable intraabdominal fibromatosis with promising surviving rates, although recurrence still occurs. Surgical margin, Ki67 proliferative index, β‐catenin, and p53 expression are not predicative for recurrence of fibromatosis.This article is protected by copyright. All rights reserved.
Source: Clinical Transplantation - December 1, 2017 Category: Transplant Surgery Authors: Zhikai Chi, Richard S Mangus, Chandrashekhar A. Kubal, Shaoxiong Chen, Jingmei Lin Tags: Original Article Source Type: research

Multivisceral transplant is a viable treatment option for patients with non ‐resectable intra‐abdominal fibromatosis
ConclusionsMultivisceral transplant (MVT) is a viable option for patients who have non‐resectable intra‐abdominal fibromatosis with promising surviving rates, although recurrence still occurs. Surgical margin, Ki67 proliferative index, β‐catenin, and p53 expression are not predicative for recurrence of fibromatosis.
Source: Clinical Transplantation - January 18, 2018 Category: Transplant Surgery Authors: Zhikai Chi, Richard S Mangus, Chandrashekhar A. Kubal, Shaoxiong Chen, Jingmei Lin Tags: ORIGINAL ARTICLE Source Type: research